Oct 29, 2025 21:58
HRTX - Heron Therapeutics, Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.05 0.0 (0.0%) | -0.01 (-0.94%) | 0.0 (-0.47%) | -0.01 (-0.94%) | -0.02 (-1.9%) | 0.02 (1.94%) | 0.0 (0.0%) | -0.02 (-1.9%) |
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.02
- Diluted EPS:
- -0.02
- Basic P/E:
- -52.5
- Diluted P/E:
- -52.5
- RSI(14) 1m:
- 40.0
- VWAP:
- 1.06
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Oct 29, 2024 20:05
Sep 17, 2024 10:00
Jul 02, 2024 12:43
Jul 01, 2024 14:31
Jun 27, 2024 15:03
Jun 26, 2024 16:57
Jun 25, 2024 10:30
Jun 24, 2024 14:19
Jun 18, 2024 13:52